The United States Patent and Trademark Office (USPTO) has issued patent US12582756B2, granting exclusive rights to Terumo Cardiovascular Systems Corporation for an "Extracorporeal oxygenator with integrated air removal system." The patent, which has a grant date of March 24, 2026, and was filed on June 21, 2023, details a medical device designed for use in extracorporeal blood flow circuits, particularly during procedures like on-pump open-heart surgery. The innovation focuses on an integrated air removal structure, potentially comprising porous hollow fibers.

This patent grant signifies a new intellectual property right for Terumo Cardiovascular Systems Corporation concerning medical device technology. While not a regulatory mandate, it impacts the competitive landscape for manufacturers of extracorporeal oxygenators and related surgical equipment. Companies operating in this space, particularly those developing or marketing similar devices, should be aware of this granted patent to avoid potential infringement claims. No immediate compliance actions are required for entities not directly involved in manufacturing or selling this specific technology, but it highlights ongoing innovation and patent activity in the medical device sector.